Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells

A recombinant deoxyribonucleoside kinase from Drosophila melanogaster with a deletion of the last 20 amino acid residues (named DmdNKΔC20) was hypothesized as a potential therapeutic tool for gene therapy due to its broad substrate specificity and better catalytic efficiency towards nucleosides and...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bosn J Basic Med Sci
Hlavní autoři: Fatima, Mahak, Ahmed, Muhammad Mubashar Iqbal, Batool, Faiza, Riaz, Anjum, Ali, Moazzam, Munch-Petersen, Birgitte, Mutahir, Zeeshan
Médium: Artigo
Jazyk:Inglês
Vydáno: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2019
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6868485/
https://ncbi.nlm.nih.gov/pubmed/30903745
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.17305/bjbms.2019.4136
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky